Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
This report contains market size and forecasts of Recombinant Trypsin Liquid Solution in global, including the following market information:
Global Recombinant Trypsin Liquid Solution Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Trypsin Liquid Solution Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Recombinant Trypsin Liquid Solution companies in 2021 (%)
The global Recombinant Trypsin Liquid Solution market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1X Sulotion Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Trypsin Liquid Solution include Novozymes, BBI Group, Roche, Thermo Fisher, Merck, Applied Biotechnology Institute, Biological Industries, Yaxin Bio and Yocon Hengye Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Trypsin Liquid Solution manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Trypsin Liquid Solution Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Recombinant Trypsin Liquid Solution Market Segment Percentages, by Type, 2021 (%)
1X Sulotion
10X Solution
Global Recombinant Trypsin Liquid Solution Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Recombinant Trypsin Liquid Solution Market Segment Percentages, by Application, 2021 (%)
Insulin Manufacturing
Vaccines Manufacturing
Cell Culture
Gene Therapy
Other
Global Recombinant Trypsin Liquid Solution Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Recombinant Trypsin Liquid Solution Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Trypsin Liquid Solution revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Trypsin Liquid Solution revenues share in global market, 2021 (%)
Key companies Recombinant Trypsin Liquid Solution sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Recombinant Trypsin Liquid Solution sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novozymes
BBI Group
Roche
Thermo Fisher
Merck
Applied Biotechnology Institute
Biological Industries
Yaxin Bio
Yocon Hengye Bio
BasalMedia
Biosera